Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€68.37
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by The_Goldman_Sachs_Gr for Insmed Inc. saw massive gains of 33.70%. The_Goldman_Sachs_Gr has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.977% | -3.977% | 152.239% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $49.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten